Chabiotech Co.,Ltd. (KOSDAQ: 085660)

Chabiotech Co.,Ltd. Statistics

Total Valuation

Chabiotech Co.,Ltd. has a market cap or net worth of KRW 860.48 billion. The enterprise value is 1.69 trillion.

Market Cap	860.48B
Enterprise Value	1.69T

Important Dates

The last earnings date was Wednesday, November 13, 2024.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

Chabiotech Co.,Ltd. has 56.31 million shares outstanding. The number of shares has increased by 0.23% in one year.

Current Share Class	n/a
Shares Outstanding	56.31M
Shares Change (YoY)	+0.23%
Shares Change (QoQ)	-78.65%
Owned by Insiders (%)	15.80%
Owned by Institutions (%)	12.07%
Float	41.41M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.85
PB Ratio	2.56
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 88.37, with an EV/FCF ratio of -15.61.

EV / Earnings	-649.36
EV / Sales	1.67
EV / EBITDA	88.37
EV / EBIT	n/a
EV / FCF	-15.61

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 0.87.

Current Ratio	0.70
Quick Ratio	0.61
Debt / Equity	0.87
Debt / EBITDA	379.43
Debt / FCF	-6.19
Interest Coverage	-1.19

Financial Efficiency

Return on equity (ROE) is -1.02% and return on invested capital (ROIC) is -1.83%.

Return on Equity (ROE)	-1.02%
Return on Assets (ROA)	-1.25%
Return on Capital (ROIC)	-1.83%
Revenue Per Employee	3.73B
Profits Per Employee	-9.59M
Employee Count	271
Asset Turnover	0.53
Inventory Turnover	21.85

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -1.60% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-1.60%
50-Day Moving Average	16,949.60
200-Day Moving Average	17,072.35
Relative Strength Index (RSI)	31.36
Average Volume (20 Days)	226,890

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Chabiotech Co.,Ltd. had revenue of KRW 1.01 trillion and -2.60 billion in losses. Loss per share was -74.23.

Revenue	1.01T
Gross Profit	260.17B
Operating Income	-38.25B
Pretax Income	-4.91B
Net Income	-2.60B
EBITDA	1.76B
EBIT	-38.25B
Loss Per Share	-74.23

Balance Sheet

The company has 276.77 billion in cash and 669.03 billion in debt, giving a net cash position of -392.27 billion or -6,965.66 per share.

Cash & Cash Equivalents	276.77B
Total Debt	669.03B
Net Cash	-392.27B
Net Cash Per Share	-6,965.66
Equity (Book Value)	768.80B
Book Value Per Share	5,958.33
Working Capital	-284.16B

Cash Flow

In the last 12 months, operating cash flow was -10.01 billion and capital expenditures -98.12 billion, giving a free cash flow of -108.13 billion.

Operating Cash Flow	-10.01B
Capital Expenditures	-98.12B
Free Cash Flow	-108.13B
FCF Per Share	-1,920.06

Margins

Gross margin is 25.76%, with operating and profit margins of -3.79% and -0.26%.

Gross Margin	25.76%
Operating Margin	-3.79%
Pretax Margin	-0.49%
Profit Margin	-0.26%
EBITDA Margin	0.17%
EBIT Margin	-3.79%
FCF Margin	-10.71%

Dividends & Yields

Chabiotech Co.,Ltd. does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.23%
Shareholder Yield	-0.23%
Earnings Yield	-0.49%
FCF Yield	-12.57%

Stock Splits

The last stock split was on June 2, 2014. It was a reverse split with a ratio of 0.7262.

Last Split Date	Jun 2, 2014
Split Type	Reverse
Split Ratio	0.7262

Scores

Chabiotech Co.,Ltd. has an Altman Z-Score of 0.74. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.74
Piotroski F-Score	n/a